Evidence Trace, complete trial record

In plain terms

In plain terms: Isometric Handgrip Training shows early signals in human research but the evidence is limited -- small trials, surrogate endpoints, or not yet independently replicated. It is an emerging area, not yet a proven one.

Isometric Handgrip Training

C Limited: small, mixed or unreplicated trials

Category Devices

Evidence Randomized trials and meta-analyses of randomized trials

Reviewed October 2026

PMIDs 36379974 · 34140663 · 42289678 · 20009767 · 28622156 · 38166533 · 39185910 · 34787298 · 42928564 · 41779689 · 18496321

The endpoint this grade is based on: Surrogate biomarker endpoint

The evidence as the record states it

Evidence record

PMID 36379974 PMID 34140663 PMID 42289678 PMID 20009767 PMID 28622156 PMID 38166533 PMID 39185910 PMID 34787298 PMID 42928564 PMID 41779689 PMID 18496321

Oliveira et al. (Journal of Human Hypertension, 2023; PMID 36379974): 7 randomized trials of handgrip training in adults with hypertension, systolic pressure 6.7 mmHg and diastolic 4.5 mmHg lower than control. Almeida et al. (Hypertension Research, 2021; PMID 34140663): 5 trials, 324 medicated hypertensive adults, systolic 8.1 mmHg lower, diastolic unchanged. Liu et al. (BMC Public Health, 2026; PMID 42289678): 20 trials, 626 participants, randomized and non-randomized, systolic 4.1 mmHg and diastolic 2.3 mmHg lower. Kelley and Kelley (Journal of Hypertension, 2010; PMID 20009767): 3 trials, 81 participants. Against these: Pagonas et al. (Journal of Hypertension, 2017; PMID 28622156), 75 adults with hypertension, 12 weeks, handgrip at 30% of maximum against a 5% sham: no change in office or 24-hour pressure, while aerobic exercise lowered both. Danielsen et al. (Journal of Sports Sciences, 2023; PMID 38166533), 48 adults, 20 weeks of home training, assessors blinded: not superior to usual care. Oliveira et al. (Journal of Cardiopulmonary Rehabilitation and Prevention, 2024; PMID 39185910), pooled ambulatory trials: no change in 24-hour systolic pressure, awake diastolic 2.0 mmHg lower. Smaller trials: Palmeira et al. (Sao Paulo Medical Journal, 2021; PMID 34787298), 63 patients in primary care, office systolic lower, ambulatory unchanged; Oliveira et al. (Clinical Physiology and Functional Imaging, 2026; PMID 42928564), 67 medicated adults, awake ambulatory pressure lower after 4 weeks, 24-hour unchanged; Champaiboon et al. (PLoS One, 2026; PMID 41779689), 30 older adults with hypertension, spring device against non-resistive squeezing, systolic 8.2 mmHg lower; Millar et al. (Journal of Cardiopulmonary Rehabilitation and Prevention, 2008; PMID 18496321), an inexpensive spring device. Mixed results with null controlled trials: Grade C.

PMID 36379974 PMID 34140663 PMID 42289678 PMID 20009767 PMID 28622156 PMID 38166533 PMID 39185910 PMID 34787298 PMID 42928564 PMID 41779689 PMID 18496321

Why Grade C and not Grade B

Grade C reflects early or limited human evidence -- small trials, surrogate endpoints, or preliminary findings not yet independently replicated. The evidence points in a promising direction but does not yet meet the standard for Grade B. A single well-powered, independently replicated trial with a meaningful endpoint would move this to Grade B or higher.

What this grade covers and what it does not

Grade C on resting systolic blood pressure in adults, most with high-normal pressure or treated hypertension. Pooled analyses of small trials find office systolic pressure about 4 to 8 mmHg lower than control (Oliveira et al., 2023; PMID 36379974; Almeida et al., 2021; PMID 34140663; Liu et al., 2026; PMID 42289678). The only trial with a sham handgrip arm found no change in office or 24-hour pressure (Pagonas et al., 2017; PMID 28622156), an assessor-blinded home trial found no benefit over usual care (Danielsen et al., 2023; PMID 38166533), and pooled 24-hour ambulatory readings did not change (Oliveira et al., 2024; PMID 39185910). Mixed results with null controlled trials meet the written C definition. WHY NOT B: B needs a good trial supported by further trials, and the trials with a sham arm or blinded assessors did not find the effect. Blood pressure is a surrogate, so B would be the ceiling in any case. WHAT THIS GRADE DOES NOT COVER: heart attack, stroke or death, which no trial measured; grip strength as a marker of health, which is observational and belongs with the biomarkers; and any specific device, since spring grippers and electronic devices were both used.

What would move this grade

A well-powered randomized trial with an objective, clinically meaningful primary endpoint and at least one independent replication would support Grade B or higher.

How this was studied

Form: Sustained squeezing of a handgrip device: electronic or spring devices, at 30% of maximal voluntary contraction in most trials (Pagonas 2017, PMID 28622156; Palmeira 2021, PMID 34787298), 20 to 50% with a spring device (Champaiboon 2026, PMID 41779689), against no exercise, usual care, non-resistive squeezing or a 5% sham (Pagonas 2017, PMID 28622156). · Dose: Four 2-minute holds alternating hands with 1 minute of rest, three times a week (Palmeira 2021, PMID 34787298; Champaiboon 2026, PMID 41779689); two 2-minute holds with each arm five times a week (Pagonas 2017, PMID 28622156); 16 minutes of effective work three times a week at home (Danielsen 2023, PMID 38166533). · Population: Adults with high-normal pressure or hypertension, most on medication: 7 trials in hypertension (Oliveira 2023, PMID 36379974); 324 medicated hypertensive adults (Almeida 2021, PMID 34140663); 75 adults with hypertension (Pagonas 2017, PMID 28622156); 48 adults with a mean age of 64 (Danielsen 2023, PMID 38166533); 30 adults over 60 with hypertension (Champaiboon 2026, PMID 41779689). · Duration: 4 to 12 weeks in most trials (Oliveira 2026, PMID 42928564; Pagonas 2017, PMID 28622156); 8 to 10 weeks in the pooled hypertension trials (Almeida 2021, PMID 34140663); 20 weeks (Danielsen 2023, PMID 38166533).

How to track whether this is working Resting office blood pressure at baseline and after 8 to 12 weeks, measured the same way each time, ideally with home or 24-hour readings as well, since the trials that used 24-hour monitoring mostly found no change. Grip strength at baseline sets the training load: the trials used 30% of maximal voluntary contraction.